A 32-gene risk index： a new prognostic approach for prostate cancer progression

作     者：Chao Cai Wei-De Zhong W. Scott McDougal Chin-Lee Wu 

作者机构：Department of Urology Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA Graduate School of Southern Medical University Guangzhou Guangdong 510515 China Department of Urology Guangzhou First Municipal People's Hospital Guangzhou Guangdong 510180 China Department of Pathology Massachusetts General Hospital and Harvard Medical School Boston MA 02114 USA 

出 版 物：《Asian Journal of Andrology》 (亚洲男性学杂志（英文版）)

年 卷 期：2013年第15卷第5期

页      面：590-591页

核心收录：

学科分类：0710[理学-生物学] 12[管理学] 1201[管理学-管理科学与工程(可授管理学、工学学位)] 07[理学] 08[工学] 09[农学] 071007[理学-遗传学] 0901[农学-作物学] 0836[工学-生物工程] 090102[农学-作物遗传育种] 081201[工学-计算机系统结构] 0812[工学-计算机科学与技术（可授工学、理学学位）] 

主　　题：A 32-gene risk index prognostic approach prostate cancer progression 

摘      要：Radical prostatectomy （RP） has been a widely accepted and standard treat-ment for clinically localized and locally advanced prostate cancer. However, effective clinical management of RP patient remains being challenged, given that conventional prognostic factors, including Gleason score, pT stage, surgical margin status and presurgery serum prostatespecific antigen （PSA）,